Bone Biologics Corporation
Bone Biologics Corporation (BBLG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BBLG · as of Jun 8, 2026
Key Statistics
Explore Bone Biologics Corporation Data
bblg stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bblg competitorsBBLG
BDRX
DHAI
GCTK
HSCS
INMStock Performance
Full HistoryAbout Bone Biologics Corporation
Bone Biologics Corporation a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an …
what is bone biologics corporation · bblg stock overview · bone biologics corporation company profile · who is bone biologics corporation ceo · bblg NASDAQ · bone biologics corporation headquarters · bone biologics corporation business segments
About Stock Overview & Key Data
Bone Biologics Corporation (BBLG) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 13, 2021. As of the latest trading session, BBLG stock price is $1.26, with a market capitalization of $2.3M. The stock has returned -72.12% over the past 12 months and -13.10% year-to-date.
In fiscal year 2025, Bone Biologics Corporation reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bone Biologics Corporation (BBLG) stock price is $1.26. The stock is traded on NASDAQ under the ticker symbol BBLG. The 52-week range is $1.05 – $6.75.